サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1375077

バイオ医薬品向け凍結乾燥サービスの欧州市場予測- 地域別分析- サービスタイプ別、エンドユーザー別

Europe Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Service Type and End User

出版日
ページ情報
英文 112 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
バイオ医薬品向け凍結乾燥サービスの欧州市場予測- 地域別分析- サービスタイプ別、エンドユーザー別
出版日: 2023年08月21日
発行: The Insight Partners
ページ情報: 英文 112 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のバイオ医薬品向け凍結乾燥サービス市場は、2023年の7億9,918万米ドルから2028年には12億4,489万米ドルに成長すると予測されています。2023年から2028年までのCAGRは9.3%と推定されます。

受託製造と凍結乾燥サービスの急成長が欧州バイオ医薬品凍結乾燥サービス市場を牽引

バイオ医薬品市場は世界的に拡大を続けており、製薬業界の主要な成長要因となっています。バイオ医薬品の非経口剤製造は、より多くの治療用生物製剤が承認されたため、最近拡大しています。バイオテクノロジー企業は、充填・仕上げのニーズを満たし、微生物汚染のリスクを低減するため、受託製造機関（CMO）に委託しています。バイオ製薬企業は、必要に応じて能力と能力を提供するために製造受託機関（CMO）に依存しています。

社内に凍結乾燥能力とオペレーションを設置するには、特殊な設備と専門知識が必要であり、費用と時間がかかります。しかし、アウトソーシングは安価であり、製造工程の効率を高める。さらに、バイオテクノロジー企業はリソースを他の分野に振り向けることができます。このように、医薬品開発企業やバイオ医薬品企業は、生産コストや収率コストを全体的に節約するために、このような業務をCMOに委託しています。数年前まで、CMO業界はニッチなサービス市場であり、バイオテクノロジー企業に追加の製造能力や特定のサービスを提供していました。バイオテクノロジー産業が大規模生産からニッチ治療や標的治療（個別化医療）へとシフトするにつれ、柔軟な操業能力、生産規模、多品目操業に対する需要が高まっています。こうした要因から、CMOへの傾倒が高まっています。凍結乾燥業務に特化した施設と専用ラインを提供するこうしたCMOの1つがジュビラン・ホリスター・スティアのコントラクト・マニュファクチャリング＆サービスです。このCMOは、第I相から商業用無菌注射剤までの無菌充填／仕上げと、一連の凍結乾燥サービスを提供しています。サービスに対する需要の高まりに対応するため、ジュビランは385平方フィートの新しい凍結乾燥機を設置しました。このように、バイオ医薬品CMOの能力と利用可能性の高まりが、バイオ医薬品向け凍結乾燥サービス市場の成長を後押ししています。

欧州のバイオ医薬品向け凍結乾燥サービス市場の概要

欧州のバイオ医薬品向け凍結乾燥サービス市場は、ドイツ、フランス、英国、イタリア、スペイン、その他欧州に区分されます。この地域の市場は予測期間中に注目すべきCAGRを記録すると予測されています。ドイツ、英国、フランスなどの国々は、欧州のバイオ医薬品市場向け凍結乾燥サービスの供給側をリードしています。これらの国々には、事業拡大に注力している様々な開発・製造受託機関（CDMO）も存在します。イタリアとスペインは、ベンチャーキャピタルの成長と企業による無機的な戦略展開により、バイオ医薬品向け凍結乾燥サービス市場の成長機会が広がっています。

欧州のバイオ医薬品向け凍結乾燥サービス市場の収益と2028年までの予測（金額）

バイオ医薬品向け欧州凍結乾燥サービスの市場セグメンテーション

欧州のバイオ医薬品向け凍結乾燥サービス市場は、サービスタイプ、エンドユーザー、国に区分されます。

サービスタイプ別に見ると、欧州のバイオ医薬品向け凍結乾燥サービス市場は、凍結乾燥サイクル開拓、臨床製造、商業製造、凍結乾燥分析サービスに区分されます。2023年の欧州バイオ医薬品向け凍結乾燥サービス市場では、商業製造分野が最大のシェアを占めています。

エンドユーザー別では、欧州のバイオ医薬品向け凍結乾燥サービス市場は製薬・バイオテクノロジー企業、研究機関、その他に区分されます。2023年の欧州バイオ医薬品向け凍結乾燥サービス市場では、製薬・バイオテクノロジー企業セグメントが最大のシェアを占めています。

国別に見ると、欧州のバイオ医薬品向け凍結乾燥サービス市場は、ドイツ、英国、フランス、スペイン、イタリア、その他欧州に区分されます。2023年の欧州バイオ医薬品用凍結乾燥サービス市場はドイツが支配的でした。

Berkshire Sterile Manufacturing社、Biofortuna社、Curia Global Inc社、Emergent BioSolutions Inc社、Jubilant HollisterStier LLC社、PCI Pharma Services社、SYNERLAB GROUP社が欧州バイオ医薬品用凍結乾燥サービス市場で事業を展開する大手企業です。

目次

第1章 イントロダクション

第2章 欧州のバイオ医薬品向け凍結乾燥サービス市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のバイオ医薬品向け凍結乾燥サービス市場- 市場情勢

  • 欧州PEST分析
  • 専門家の見解

第5章 欧州のバイオ医薬品向け凍結乾燥サービス市場-主要市場力学

  • 市場促進要因
    • 凍結乾燥製品に対する需要の高まり
    • 受託製造と凍結乾燥サービスの急成長
  • 市場抑制要因
    • 凍結乾燥プロセスに伴うデメリット
  • 市場機会
    • 高度な凍結乾燥技術の登場
  • 今後の動向
    • siRNAおよび抗体ベースの製剤数の増加
  • 促進要因と阻害要因の影響分析

第6章 欧州のバイオ医薬品向け凍結乾燥サービス市場分析

  • 欧州のバイオ医薬品向け凍結乾燥サービス市場の収益予測と分析

第7章 欧州のバイオ医薬品向け凍結乾燥サービス市場分析と2028年までの予測-サービスタイプ別

  • 欧州のバイオ医薬品向け凍結乾燥サービス市場：サービスタイプ別2022年・2028年（%）
  • 商業用製造
  • 臨床製造
  • 凍結乾燥サイクル開発
  • 凍結乾燥分析サービス

第8章 欧州のバイオ医薬品向け凍結乾燥サービス市場分析と2028年までの予測：エンドユーザー別

  • 欧州のバイオ医薬品向け凍結乾燥サービス市場：エンドユーザー別2022年・2028年（%）
  • 製薬企業およびバイオテクノロジー企業
  • 研究機関
  • その他

第9章 バイオ医薬品向け凍結乾燥サービス市場-2028年までの収益と予測- 欧州分析

第10章 欧州のバイオ医薬品向け凍結乾燥サービス市場-業界情勢

  • バイオ医薬品向け欧州凍結乾燥サービス市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Berkshire Sterile Manufacturing
  • PCI Pharma Services
  • Curia Global Inc
  • Emergent BioSolutions Inc
  • Jubilant HollisterStier LLC.
  • Biofortuna
  • SYNERLAB GROUP

第12章 付録

図表

List Of Tables

  • Table 1. Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. France: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. France: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. UK: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. UK: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Recent Inorganic Growth Strategies in the Europe Lyophilization Services for Biopharmaceuticals Market
  • Table 14. Recent Organic Growth Strategies in the Europe Lyophilization Services for Biopharmaceuticals Market
  • Table 15. Glossary of Terms

List Of Figures

  • Figure 1. Europe Lyophilization Services for Biopharmaceuticals Market Segmentation
  • Figure 2. Europe Lyophilization Services for Biopharmaceuticals Market, by Country
  • Figure 3. Europe Lyophilization Services for Biopharmaceuticals Market Overview
  • Figure 4. Commercial Manufacturing Segment Held Largest Share of Service Type Segment in Europe Lyophilization Services for Biopharmaceuticals Market
  • Figure 5. The UK Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Europe: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. Europe Lyophilization Services for Biopharmaceuticals Market Impact Analysis of Drivers and Restraint
  • Figure 9. Europe Lyophilization Services for Biopharmaceuticals Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
  • Figure 11. Commercial Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Clinical Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Lyophilization Cycle Development: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Freeze Drying Analytical Services: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 15. Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
  • Figure 16. Pharmaceutical and Biotechnology Companies: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Research Institutes: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Others: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Europe Lyophilization Services for Biopharmaceuticals Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. Europe Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
  • Figure 21. Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. France: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. UK: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Italy: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Spain: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Growth Strategies in the Europe Lyophilization Services for Biopharmaceuticals Market
目次
Product Code: BMIRE00028752

The Europe lyophilization services for biopharmaceuticals market is expected to grow from US$ 799.18 million in 2023 to US$ 1,244.89 million by 2028. It is estimated to register a CAGR of 9.3% from 2023 to 2028.

Rapid Growth in Contract Manufacturing and Lyophilization Services Fuel Europe Lyophilization Services for Biopharmaceuticals Market

The biopharmaceuticals market continues to expand worldwide, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies depend on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed.

Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. As the biotechnology industry shifts from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. One such CMO that provides specialized facilities and dedicated lines for lyophilization operations is Jubilant HollisterStier Contract Manufacturing & Services. The CMO offers sterile fill/finish of Phase I through a commercial sterile injectable and a full suite of lyophilization services. To keep up with the growing demand for its services, Jubilant installed a new 385-square-foot lyophilizer. Thus, the rising capability and availability of biopharma CMOs fuel the lyophilization services for biopharmaceuticals market growth.

Europe Lyophilization Services for Biopharmaceuticals Market Overview

The Europe lyophilization services for biopharmaceuticals market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The market in this region is estimated to register a notable CAGR during the forecast period. Countries such as Germany, the UK, and France lead the supply side of the lyophilization services for the biopharmaceutical market in Europe. These countries also have the presence of various contract development and manufacturing organizations (CDMOs) that are focused on business expansion in these countries. Italy and Spain have wider growth opportunities for the lyophilization services for biopharmaceuticals market owing to the growing venture capital and inorganic strategic developments by companies.

Europe Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Million)

Europe Lyophilization Services for Biopharmaceuticals Market Segmentation

The Europe lyophilization services for biopharmaceuticals market is segmented into service type, end user, and country.

Based on service type, the Europe lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest share of the Europe lyophilization services for biopharmaceuticals market in 2023.

By end user, the Europe lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and others. The pharmaceutical & biotechnology companies segment held the largest share of the Europe lyophilization services for biopharmaceuticals market in 2023.

Based on country, the Europe lyophilization services for biopharmaceuticals market is segmented into Germany, UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe lyophilization services for biopharmaceuticals market in 2023.

Berkshire Sterile Manufacturing, Biofortuna, Curia Global Inc, Emergent BioSolutions Inc, Jubilant HollisterStier LLC., PCI Pharma Services, and SYNERLAB GROUP are the leading companies operating in the Europe lyophilization services for biopharmaceuticals market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe lyophilization services for biopharmaceuticals market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Lyophilization Services for Biopharmaceuticals Market - by Service Type
    • 1.3.2 Europe Lyophilization Services for Biopharmaceuticals Market - by End User
    • 1.3.3 Europe Lyophilization Services for Biopharmaceuticals Market - by Country

2. Europe Lyophilization Services for Biopharmaceuticals Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Lyophilization Services for Biopharmaceuticals Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Expert's Opinion

5. Europe Lyophilization Services for Biopharmaceuticals Market - Key Market Dynamics

  • 5.1 Market Driver
    • 5.1.1 Rising Demand for Lyophilized Products
    • 5.1.2 Rapid Growth in Contract Manufacturing and Lyophilization Services
  • 5.2 Market Restraints
    • 5.2.1 Demerits Associated with Lyophilization Process
  • 5.3 Market Opportunities
    • 5.3.1 Launch of Advanced Lyophilization Technology
  • 5.4 Future Trends
    • 5.4.1 Growing Number of siRNA and Antibody-Based Formulations
  • 5.5 Impact Analysis of Drivers and Restraints

6. Lyophilization Services for Biopharmaceuticals Market - Europe Analysis

  • 6.1 Europe Lyophilization Services for Biopharmaceuticals Market Revenue Forecast and Analysis

7. Europe Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by Service Type

  • 7.1 Overview
  • 7.2 Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type 2022 & 2028 (%)
  • 7.3 Commercial Manufacturing
    • 7.3.1 Overview
    • 7.3.2 Commercial Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Clinical Manufacturing
    • 7.4.1 Overview
    • 7.4.2 Clinical Manufacturing: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Lyophilization Cycle Development
    • 7.5.1 Overview
    • 7.5.2 Lyophilization Cycle Development: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Freeze Drying Analytical Services
    • 7.6.1 Overview
    • 7.6.2 Freeze Drying Analytical Services: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

8. Europe Lyophilization Services for Biopharmaceuticals Market Analysis and Forecast to 2028 - by End User

  • 8.1 Overview
  • 8.2 Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2022 & 2028 (%)
  • 8.3 Pharmaceutical and Biotechnology Companies
    • 8.3.1 Overview
    • 8.3.2 Pharmaceutical and Biotechnology Companies: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Research Institutes
    • 8.4.1 Overview
    • 8.4.2 Research Institutes: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)

9. Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 -Europe Analysis

  • 9.1 Overview
    • 9.1.1 Europe Lyophilization Services for Biopharmaceuticals Market, by Country, 2022 & 2028 (%)
      • 9.1.1.1 Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.1.3 Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.1.4 Germany: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.2 France: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 France: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.2.3 France: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.2.4 France: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.3 UK: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 UK: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.3.3 UK: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.3.4 UK: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.4 Italy: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.4.3 Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.4.4 Italy: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.5 Spain: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.5.3 Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.5.4 Spain: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)
      • 9.1.1.6 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market - Revenue and Forecast to 2028 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by Service Type, 2020-2028 (US$ Million)
        • 9.1.1.6.4 Rest of Europe: Europe Lyophilization Services for Biopharmaceuticals Market, by End User, 2020-2028 (US$ Million)

10. Europe Lyophilization Services for Biopharmaceuticals Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Europe Lyophilization Services for Biopharmaceuticals Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Berkshire Sterile Manufacturing
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 PCI Pharma Services
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Curia Global Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Emergent BioSolutions Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Jubilant HollisterStier LLC.
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Biofortuna
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 SYNERLAB GROUP
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms